Nephros (NEPH) Change in Account Payables (2014 - 2026)
Nephros (NEPH) posted Change in Account Payables of $499000.0 for Q2 2026, down 11.21% on a QoQ basis from $562000.0 in Q1 2026, and up 516.05% year-over-year from $81000.0 in Q2 2025.
Powered by 
Analysis
Nephros (NEPH) Change in Account Payables (2014 - 2026) Analysis & Trends
Nephros has reported Change in Account Payables for 13 years, with the latest figure at $499000.0 in Q2 2026.
- On a quarterly basis, Change in Account Payables rose 516.05% year-over-year to $499000.0 in Q2 2026; TTM through Jun 2026 was $1.3 million, a 352.16% increase from a year earlier, with the FY2025 full-year figure at $259000.0, up 217.73% from the prior year.
- Change in Account Payables was $499000.0 for Q2 2026 at Nephros, down from $562000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $562000.0 in Q1 2026, with the low at -$766000.0 in Q3 2024.
- Average Change in Account Payables over 5 years is $35555.6, with a median of $56500.0 recorded in 2023.
- The sharpest annual moves came in 2022 and 2024: Change in Account Payables slumped 675.0% in 2022, then soared 1261.9% in 2024.
- Over 5 years, Change in Account Payables stood at -$38000.0 in 2022, then jumped by 278.95% to $68000.0 in 2023, then jumped by 277.94% to $257000.0 in 2024, then slumped by 111.28% to -$29000.0 in 2025, then jumped by 1820.69% to $499000.0 in 2026.
- The last three Change in Account Payables figures came in at $499000.0 (Q2 2026), $562000.0 (Q1 2026), and -$29000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | -52.50 Mn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | - |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 71.00 Mn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | - |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | - |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 4.30 Mn |
| 10 | Nephros | 48.31 Mn | 43.62 Mn | 4.03 Mn | 499,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 499,000.00 |
| Mar 31, 2026 | 562,000.00 |
| Dec 31, 2025 | -29,000.00 |
| Sep 30, 2025 | 312,000.00 |
| Jun 30, 2025 | 81,000.00 |
| Mar 31, 2025 | -105,000.00 |
| Dec 31, 2024 | 257,000.00 |
| Sep 30, 2024 | -766,000.00 |
| Jun 30, 2024 | 45,000.00 |
| Mar 31, 2024 | 244,000.00 |
| Dec 31, 2023 | 68,000.00 |
| Sep 30, 2023 | 502,000.00 |
| Jun 30, 2023 | -416,000.00 |
| Mar 31, 2023 | -21,000.00 |
| Dec 31, 2022 | -38,000.00 |
| Sep 30, 2022 | -632,000.00 |
| Jun 30, 2022 | 514,000.00 |
| Mar 31, 2022 | -437,000.00 |
| Dec 31, 2021 | 685,000.00 |
| Sep 30, 2021 | -462,000.00 |